[Table/Fig-3]:
Study | Place | Sample size |
Test Done |
Methodology | Results |
---|---|---|---|---|---|
Ashshi, 2015 [18] | Saudi Arabia |
100 | NS1 IgM IgG |
ELISA | NS1: 1% IgM: 6% IgG: 7% |
Linnen et al., 2008 [21] | Honduras, Brazil and Australia | 13,731 | RNA detection | Transcription mediated amplification | 0.30%- Honduras 0.06%- Brazil 0%- Australia |
Mohammed et al.,2008 [22] | Peurto Rico |
16,521 | RNA detection | Transcription mediated amplification | 0.07% |
Leny lobo Dias et al.,2012 [23] | Brazil | 500 | RNA detection | RealTime Reverse Transcriptase PCR | 0.4% |
Ribas-Silva et al.,2012 [24] | Brazil | 213 | IgM IgG |
Immunochromato-graphic test | IgM: 0 % IgG: 1.4% |
Faddy et al., 2013 [25] | North Queensland, Australia | 5453 | IgM IgG* |
ELISA | IgM: 0.22% IgG: 9.43% |
Harif et al., 2014 [26] | Malaysia | 360 | IgM IgG |
ELISA | IgM: 4.2% IgG: 42.0% |
Low et al., 2015 [27] | Singapore | 3,995 | IgG IgM |
ELISA | IgG: 52% IgM: 2.83% |
Mangwana, 2015 [28] | New Delhi, India | 1709 | NS1 Antigen | ELISA | 0% |
This study | New Delhi, India | 200 | IgG IgM RNA |
ELISA, Reverse Transcriptase PCR | IgG: 58% IgM: 13.5% RNA: 0% |
* IgG testing was done on selective samples